3.1.3 Hypercholesterolemia Hypercholesterolemia is a systemic metabolic disease characterized by abnormal lipid metabolism due to genetic factors, high-fat intake, lack of exercise, etc
These side effects were mild-to-moderate for most patients and decreased over time with continued exposure
A good next step is to see if you qualify for a personalized GLP-1 program, especially if you want support with dosing, follow-up, and routine questions
Prime Health is not affiliated with those manufacturers
OH attacks thymine or deoxyguanosine bases to generate 5-hydroxy-6-hydrothymine or 8-hydroxy-2'-deoxyguanosine (8-OHdG)
Overall, NICE 2026 formalises a cardio-renal protective strategy in T2D management, positioning SGLT-2 inhibitors as foundational therapy alongside metformin, and reinforcing precision-based, patient-centred care